These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9126871)

  • 1. Failure of the nitric oxide synthase inhibitor to stimulate duodenal bicarbonate secretion in streptozotocin-diabetic rats.
    Takehara K; Tashima K; Kato S; Takeuchi K
    Life Sci; 1997; 60(17):1505-14. PubMed ID: 9126871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired duodenal bicarbonate secretion in diabetic rats. Salutary effect of nitric oxide synthase inhibitor.
    Takeuchi K; Hirata T; Korolkiewicz R; Sugawa Y; Kubomi M
    J Physiol Paris; 1997; 91(3-5):235-40. PubMed ID: 9403801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in duodenal bicarbonate secretion and mucosal susceptibility to acid in diabetic rats.
    Takehara K; Tashima K; Takeuchi K
    Gastroenterology; 1997 Feb; 112(2):418-28. PubMed ID: 9024295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in gastric HCO-3 secretory response to NG-nitro-L-arginine methyl ester in rats following repeated administration.
    Takeuchi K; Takehara K; Kato S; Asada Y; Yasuhiro T
    J Gastroenterol Hepatol; 1996 Dec; 11(12):1164-70. PubMed ID: 9034937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
    Takeuchi K; Takehara K; Kato S
    J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying stimulation of gastroduodenal HCO3- secretion by NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase, in rats.
    Takeuchi K; Takehara K; Okabe S
    Jpn J Pharmacol; 1994 Nov; 66(3):295-302. PubMed ID: 7869616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation by nitric oxide synthase inhibitors of gastric and duodenal HCO3- secretion in rats.
    Takeuchi K; Ohuchi T; Miyake H; Okabe S
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1512-9. PubMed ID: 7690403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nitric oxide in renal function in rats with short and prolonged periods of streptozotocin-induced diabetes.
    Suanarunsawat T; Klongpanichapak S; Chaiyabutr N
    Diabetes Obes Metab; 1999 Nov; 1(6):339-46. PubMed ID: 11225650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Paramar AN; Balaraman R
    Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX and NOS isoforms involved in acid-induced duodenal bicarbonate secretion in rats.
    Takeuchi K; Kagawa S; Mimaki H; Aoi M; Kawauchi S
    Dig Dis Sci; 2002 Sep; 47(9):2116-24. PubMed ID: 12353866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide and penile erection in streptozotocin-diabetic rats.
    Ari G; Vardi Y; Finberg JP
    Clin Sci (Lond); 1999 Apr; 96(4):365-71. PubMed ID: 10087243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
    Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R
    Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats.
    Smith JM; Paulson DJ; Romano FD
    J Mol Cell Cardiol; 1997 Sep; 29(9):2393-402. PubMed ID: 9299363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nitric oxide synthase inhibitors on duodenal alkaline secretion in anesthetized rats.
    Takeuchi K; Ohuchi T; Miyake H; Niki S; Okabe S
    Eur J Pharmacol; 1993 Jan; 231(1):135-8. PubMed ID: 7680316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric acid secretion in streptozotocin-diabetic rats--different responses to various secretagogues.
    Tashima K; Nishijima M; Fujita A; Kawauchi S; Takeuchi K
    J Physiol Paris; 2000; 94(1):11-7. PubMed ID: 10761683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid secretory changes in streptozotocin-diabetic rats: different responses to various secretagogues.
    Tashima K; Nishijima M; Fujita A; Kubomi M; Takeuchi K
    Dig Dis Sci; 2000 Jul; 45(7):1352-8. PubMed ID: 10961714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
    Dewhurst M; Omawari N; Tomlinson DR
    Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of diabetes on non-adrenergic, non-cholinergic relaxation induced by GABA and electrical stimulation in the rat isolated duodenum.
    Kaputlu I; Ozdem S; Sadan G; Gökalp O
    Clin Exp Pharmacol Physiol; 1999 Sep; 26(9):724-8. PubMed ID: 10499162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide may be required to prevent hypertension at the onset of diabetes.
    Fitzgerald SM; Brands MW
    Am J Physiol Endocrinol Metab; 2000 Oct; 279(4):E762-8. PubMed ID: 11001756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism underlying stimulation of gastric HCO3- secretion by the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester in rats.
    Takeuchi K; Ohuchi T; Tachibana M; Okabe S
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S50-4. PubMed ID: 7533553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.